Successful Proof Principal Mouse Trial with Chronoscreen™ Validated Compound
Chronos Therapeutics completes successful proof of principle mouse trial with a…
RDC5 Reduces the Levels of Toxic Protein Aggregates
In pre-clinical models, Chronos Therapeutics' patented compound RDC5 and CHR1…